Mesoblast

MESO

Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

Mesoblast has been a target of short sellers for a while. The current short interest of 2.43% is roughly at the average of the last 12 months (2.20%).